Plasma Homocysteine Level and the Angiographic Extent of Coronary Artery Disease

Abstract

Recent epidemiologic studies have shown that moderately elevated plasma homocysteine concentrations are associated with an increased risk for the development of atherosclerotic cardiovascular diseases. But, it is not known whether moderate hyperhomocysteinemia is associated with the angiographic extent of atherosclerotic cardiovascular disease in patients with coronary artery disease (CAD). A possible relationship was investigated between admission plasma homocysteine level and the angiographic extent of coronary artery disease in patients with CAD. In this study, 156 consecutive patients presenting with coronary artery disease (group 1) and control group (group 2) of 35 age-matched persons with normal coronary angiography were enrolled. Blood samples for homocysteine were obtained on admission. Plasma homocysteine concentration was measured with high-performance liquid chromatography with fluorescence detection. Radiographs from coronary angiography were viewed and scored using Sullivan’s method to assess the atherosclerotic involvement of coronary artery disease. There were significant elevations in homocysteine level in group 1 compared to group 2 (15.59 ±5.7 µmol/L, 9.24 ±1.50 µmol/L; respectively, p<0.001). All scores (demonstrated angiographic extension of CAD) correlated significantly with plasma homocysteine levels; however, the Sullivan’s extent score correlated more closely (r =0.68, p<0.001) than both the stenosis score (r =0.44, p<0.01) and vessel score (r =0.35, p<0.05). Elevated homocysteine levels in patients with coronary artery disease correlated with the angiographic extent of atherosclerotic disease.

Get full access to this article

View all access options for this article.

References

Brown CA , McKinney KQ , Kaufman JS , et al : A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease. J Cardiovasc Risk 7:197-200, 2000.

Mudd SH , Skovby F , Levy HL , et al : The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37:1-31, 1985.

Boushey CJ , Beresford SA , Omenn GS , et al : A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. JAMA 274:1049-1057, 1995.

Verhoef P , Kok FJ , Kruyssen DA , et al : Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 17:989-995, 1997.

Selhub J , Jacques PF , Bostom AG , et al : Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 332:286-291, 1995.

Graham IM , Daly LE , Refsum HM , et al : Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277:1775-1781, 1997.

Aronow WS , Ahn C : Association between plasma homocysteine and peripheral arterial disease in older persons. Coron Artery Dis 9:49-50, 1998.

Robinson K : Homocysteine, B vitamins, and risk of cardiovascular disease. Heart 83:127-130, 2000.

Lentz SR , Sadler JE : Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 88:1906-1914, 1991.

10.

Rodgers GM , Conn MT : Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 75:895-901, 1990.

11.

Durand P , Lussier-Cacan S , Blache D : Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J 11:1157-1168, 1997.

12.

Dudman NP , Hicks C , Wang J , et al : Human arterial endothelial cell detachment in vitro: Its promotion by homocysteine and cysteine. Atherosclerosis 91:77-83, 1991.

13.

Stubbs PJ , Al-Obaidi MK , Conroy RM , et al : Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes. Circulation 102:605-610, 2000.

14.

WHO : Working group on the Establishment of Ischaemic Heart Disease Registers: Report of the Fifth Working Group. Copenhagen: WHO Report No. Eur. 8201 (5), 1971.

15.

Refsum H , Ueland PM , Svardal AM : Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem 35:1921-1927, 1989.

16.

Fiskerstrand T , Refsum H , Kvalheim G , et al : Homocysteine and other thiols in plasma and urine: Automated determination and sample stability. Clin Chem 39:263-271, 1993.

17.

Sullivan DR , Marwick TH , Freedman SB : A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 119:1262-1267, 1990.

18.

Al-Obaidi MK , Stubbs PJ , Collinson P , et al : Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes. J Am Coll Cardiol 36:1217-1222, 2000.

19.

Schnyder G , Pin R , Roffi M , et al : Association of plasma homocysteine with the number of major coronary arteries severely narrowed. Am J Cardiol 88:1027-1030, 2001.

20.

Al-Obaidi MK , Stubbs PJ , Amersey R , et al : Acute and convalescent changes in plasma homocysteine concentrations in acute coronary syndromes. Heart 85:380-384, 2001.